Furthermore, combined amplification of PIK3CA and SOX2 is emerging as a valuable and easy-to-implement tool for cancer risk stratification that may complement histopathological diagnosis to distinguish high-risk patients more accurately, and to ultimately improve personalized treatment decisions. The gene discussed is PIK3CA; the disease is cancer.